| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2022 - PRIN bando 2022 |
Supporting medication adherence by the Elderly: development of an action framework for different healthcare settings
|
|
Ongoing | 2023 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Breaking the barrier -An integrated multidisciplinary approach to killGram-negative bacteria through existing antibiotics by making their outer membrane permeable (BREAKthrough)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Evaluation of Castanea sativa by-products as a source of bioactive molecules against Helicobacter pylori-induced inflammation: a novel sustainable strategy Acronym: CastACTIVE
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Adoptive cell transfer of metabolic reprogrammed T regulatory cells to control atherosclerosis progression and to prevent end organ damage in cardiovascular disease.
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Linking inflammation to progression of neurodegeneration in Parkinson’s disease (LINKING PARK)
|
|
Ongoing | 2023 |
| AL_RIC - Bandi da altri enti di ricerca |
Valutazione della funzionalità mitocondriale nelle sindromi da Long COVID-19
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Pharmacological inhibition and genetic deletion of PCSK9: in vitro and in vivo studies on smooth muscle cell aortic calcification
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Stress granules as possible mediators of cardiac damage by dysfunctional HDL in acute coronary syndrome: towards novel pharmacological targets
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Decoding distinctive features of EXtracellular vesicles In TDP-43 proteinopathies - EXIT
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Endometriosis and related pain: novel pathogenetic targets for non-hormonal drugs
|
|
Ongoing | 2023 |
